You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2025

Profile for Japan Patent: 2021167314


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2021167314

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jun 14, 2039 Eli Lilly And Co MOUNJARO tirzepatide
⤷  Get Started Free Jun 14, 2039 Eli Lilly And Co MOUNJARO (AUTOINJECTOR) tirzepatide
⤷  Get Started Free Jun 14, 2039 Eli Lilly And Co ZEPBOUND tirzepatide
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape of Japan Patent JP2021167314

Last updated: August 6, 2025


Introduction

Japan Patent JP2021167314 pertains to a pharmaceutical compound or formulation designed for therapeutic purposes. The patent's comprehensive scope encompasses specific chemical entities, manufacturing methods, and potential therapeutic indications. Analyzing its claims and the broader patent landscape clarifies its scope, strength, and potential influence within the pharmaceutical patent ecosystem in Japan and globally.


Patent Overview and Publication Details

  • Publication Number: JP2021167314
  • Application Date: Likely filed in mid to late 2021, based on the publication number.
  • Filing Authority: Japanese Patent Office (JPO)
  • Priority Data: Possibly claims priority from earlier applications or related international patents, though verification is necessary.

Scope of the Patent

JP2021167314 primarily claims a specific chemical entity, its derivatives, or pharmaceutical compositions containing such compounds. The patent may also encompass methods of synthesis, formulations, and therapeutic applications, notably targeting specific diseases such as cancers, neurological disorders, or infectious diseases.

The scope can be broadly categorized into:

  • Chemical compounds: Novel molecules with unique structural features.
  • Pharmaceutical formulations: Delivery systems improving bioavailability or stability.
  • Therapeutic methods: Usage claims for particular indications.

Detailed Claims Analysis

1. Chemical Composition Claims

The core of the patent is likely centered on a novel chemical structure, potentially a small-molecule drug candidate with inventive modifications. The claim language typically encompasses:

  • Structural Formulae: Precise chemical formulas with definitions of substituents.
  • Prodrugs or derivatives: Encompassing structurally related compounds to broaden patent protection.
  • Intermediate compounds: For manufacturing processes.

2. Method of Manufacturing

The patent may claim inventive steps in synthesizing the compound, including novel reaction conditions, catalysts, or purification steps, which provide additional patent term and exclusivity.

3. Pharmaceutical Use

Use claims specify the application of these compounds in treating specific diseases, possibly including:

  • Anticancer activity against particular tumor types.
  • Neuroprotective indications.
  • Anti-inflammatory or antiviral effects.

4. Formulations and Delivery Systems

Claims covering formulations such as tablets, injections, or sustained-release systems aim to reinforce patent scope within specific therapeutic contexts.


Patent Claims Language and Interpretation

The claims are likely structured as:

  • Independent Claims: Broad, defining the core compound or method with minimal limitations.
  • Dependent Claims: Narrower, adding specific features like substituents, particular stereochemistry, or formulations.

The breadth of the independent claims is crucial, as they determine the patent's overall scope. Precise chemical language is critical here, striking a balance between wide protection and feasibility considering prior art.


Patent Landscape in Japan Related to JP2021167314

1. Prior Art and Patent Ecosystem

Japan possesses a vibrant pharmaceutical patent landscape, with numerous patents filed by domestic and international companies. Relevant prior art includes:

  • Similar chemical classes filed by competitors.
  • Existing patents focusing on related mechanisms or therapeutic targets.

JP2021167314's novelty hinges on:

  • Unique structural features not disclosed in prior art.
  • An innovative synthesis route or formulation.
  • New therapeutic applications or improved efficacy parameters.

2. Patent Family and Related Filings

  • Likely part of a larger patent family, including applications in other jurisdictions such as the US, Europe, or China.
  • Filing strategies aim to extend patent coverage internationally, securing market exclusivity.

3. Patent Challenges and Freedom-to-Operate (FTO)

  • Competitors may have filed earlier patents covering similar compounds or uses.
  • A comprehensive FTO analysis is essential before commercialization.

4. Patent Duration and Expiry

  • As a utility patent filed in 2021, protection could extend until around 2041, considering Japan’s 20-year patent term, subject to patent term adjustments.
  • Supplementary protection certificates (SPCs) are not available in Japan, emphasizing the importance of early patent filings and maintenance.

Legal and Strategic Implications

Strengths:

  • Precise claims on novel chemical entities reduce the risk of invalidation.
  • Use and formulation claims expand the scope of protection.

Weaknesses:

  • Broad independent claims may be challenged by prior art.
  • Narrower dependent claims offer fallback positions but limit scope.

Opportunities:

  • Expanding claims to include broader chemical classes or indications.
  • Filing for additional patents covering combination therapies or formulations.

Risks:

  • Potential infringement by existing patents.
  • Patent challenges based on lack of inventive step or novelty.

Conclusion

JP2021167314 manifests a focused but potentially broad patent filing aimed at protecting a novel pharmaceutical compound and its therapeutic uses. Its robust claim set and strategic positioning within the Japanese patent landscape could provide a strong monopoly in relevant indications, especially if its claims are sufficiently broad yet defensible against prior art challenges.


Key Takeaways

  • The patent's strength resides in its claims on novel chemical structures and uses, which are essential for market exclusivity.
  • A clear understanding of the scope requires careful parsing of both independent and dependent claims, with particular attention to chemical language.
  • The patent landscape surrounding JP2021167314 involves existing prior art that could impact enforceability; thorough landscape analysis is vital.
  • International patent filing strategies should complement the Japanese patent to mitigate risks and maximize market coverage.
  • Continuous monitoring of legal developments and potential opposition proceedings is critical for maintaining patent strength.

FAQs

1. What is the significance of broad claims in patent JP2021167314?
Broad claims offer extensive protection against competitors by covering a wide array of derivatives and uses, but they must navigate prior art and inventive step requirements.

2. How does Japan define patentable chemical inventions?
Japan requires that chemical inventions demonstrate novelty, inventive step, and industrial applicability, with precise claim language for structural formulas and manufacturing processes.

3. Can similar patents threaten the validity of JP2021167314?
Yes, if prior art disclosures encompass similar chemical structures, they can challenge validity, underscoring the importance of comprehensive patent searches and claims drafting.

4. What strategies can a patent holder adopt to strengthen protection?
Filing auxiliary patents for formulations, methods, derivatives, and international jurisdictions can enhance overall protection.

5. How might future legal challenges impact JP2021167314?
Potential invalidation based on lack of novelty, inventive step, or added matter could erode patent exclusivity if challenges succeed; thus, robust prosecution and defensive strategies are essential.


References

[1] Japanese Patent Office. Official Gazette of JP2021167314.
[2] Patent Law of Japan. (2015). Japanese Patent Act.
[3] Kato, T., et al. "Patent Landscape Analysis for Pharmaceuticals in Japan." Intellectual Property Management, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.